Verition Fund Management LLC Astrazeneca PLC Call Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 May 03, 2022	SELL	$54.02 - $63.83 $8.69 Million - $10.3 Million	-160,800 Reduced 56.82%	122,200 $7.12 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $3.8 Million - $4.16 Million	-68,400 Reduced 19.46%	283,000 $17 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $769,878 - $956,862	15,900 Added 4.74%	351,400 $21 Million
Q1 2021 May 18, 2021	BUY	$47.16 - $54.44 $11.8 Million - $13.6 Million	250,500 Added 294.71%	335,500 $16.7 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $4.12 Million - $4.93 Million	85,000 New	85,000 $4.25 Million

1,247

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $239B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.